Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 06, 2022

SELL
$351.38 - $448.68 $3,513 - $4,486
-10 Reduced 21.74%
36 $14,000
Q3 2021

Oct 08, 2021

BUY
$372.64 - $458.3 $17,141 - $21,081
46 New
46 $19,000
Q1 2019

Apr 09, 2019

SELL
$104.82 - $146.73 $7,547 - $10,564
-72 Closed
0 $0
Q4 2018

Jan 15, 2019

BUY
$105.09 - $137.23 $7,566 - $9,880
72 New
72 $8,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Vigilant Capital Management, LLC Portfolio

Follow Vigilant Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vigilant Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vigilant Capital Management, LLC with notifications on news.